Developing tools for defining and establishing pathways of toxicity

Archives of Toxicology

Volumn 89, Issue 5, 2015, Pages 809-812

  Andersen, Melvin E ^a   McMullen, Patrick D ^a   Krewski, Daniel ^b,c  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

^c RISK SCIENCES INTERNATIONAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR SP1;

ANIMAL; INTOXICATION; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; MALE; MPTP POISONING; SP1 TRANSCRIPTION FACTOR;

EID: 84937759207     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-015-1512-y     Document Type: Editorial

References (25)

1. Adeleye Y et al (2014) Implementing toxicity testing in the 21st Century (TT21C): making safety decisions using toxicity pathways, and progress in a prototype risk assessment. Toxicology. doi:10.1016/j.tox.2014.02.007
2. Andersen ME, Krewski D (2010) The vision of toxicity testing in the 21st century: moving from discussion to action. Toxicol Sci 117:17–24. doi:10.1093/toxsci/kfq188
3. Andersen ME, Clewell HJ, Carmichael PL, Boekelheide K (2011) Can case study approaches speed implementation of the Nrc report: “Toxicity Testing in the 21st Century: A Vision and a Strategy?”. ALTEX 28:175–182
4. Attene-Ramos MS et al (2015) Profiling of the Tox21 chemical collection for mitochondrial function to identify compounds that acutely decrease mitochondrial membrane potential. Environ Health Perspect 123:49–56. doi:10.1289/ehp.1408642
5. Bar-Joseph Z et al (2003) Computational discovery of gene modules and regulatory networks. Nat Biotechnol 21:1337–1342. doi:10.1038/nbt890
6. Boekelheide K, Andersen ME (2010) A mechanistic redefinition of adverse effects: a key step in the toxicity testing paradigm shift. ALTEX 27:243–252
7. Dere E, Lo R, Celius T, Matthews J, Zacharewski TR (2011) Integration of genome-wide computation Dre search, Ahr chip–chip and gene expression analyses of Tcdd-elicited responses in the mouse liver. BMC Genomics 12:365. doi:10.1186/1471-2164-12-365
8. Friedman N (2004) Inferring cellular networks using probabilistic graphical models. Science 303:799–805. doi:10.1126/science.1094068
9. Hartung T, McBride M (2011) Food for thought…On mapping the human toxome. ALTEX 28:83–93
10. Judson RS et al (2010) Analysis of eight oil spill dispersants using rapid, in vitro tests for endocrine and other biological activity. Environ Sci Technol 44:5979–5985. doi:10.1021/es102150z
11. Krewski D et al (2010) Toxicity testing in the 21st century: a vision and a strategy. J Toxicol Environ Health B Crit Rev 13:51–138. doi:10.1080/10937404.2010.483176
12. Krewski D, Westphal M, Al-Zoughool M, Croteau MC, Andersen ME (2011) New directions in toxicity testing. Annu Rev Public Health 32:161–178. doi:10.1146/annurev-publhealth-031210-101153
13. Krewski D et al (2014) A framework for the next generation of risk science. Environ Health Perspect 122:796–805. doi:10.1289/ehp.1307260
14. Maertens A, Luechtefeld T, Kleensang A, Hartung T (2015) MPTP’s pathway of toxicity indicates central role of transcription factor Sp1. Arch Toxiol (this issue). doi:10.1007/s00204-015-1509-6
15. McMullen PD et al (2014) A map of the PPARalpha transcription regulatory network for primary human hepatocytes. Chem Biol Interact 209:14–24. doi:10.1016/j.cbi.2013.11.006
16. Miller RM et al (2004) Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra. J Neurosci 24:7445–7454. doi:10.1523/JNEUROSCI.4204-03.2004
17. Sand S, Portier CJ, Krewski D (2011) A signal-to-noise crossover dose as the point of departure for health risk assessment. Environ Health Perspect 119:1766–1774. doi:10.1289/ehp.1003327
18. Segal E, Shapira M, Regev A, Pe’er D, Botstein D, Koller D, Friedman N (2003) Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet 34:166–176. doi:10.1038/ng1165
19. Simmons SO, Fan CY, Ramabhadran R (2009) Cellular stress response pathway system as a sentinel ensemble in toxicological screening. Toxicol Sci 111:202–225. doi:10.1093/toxsci/kfp140
20. Sipes NS et al (2013) Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol 26:878–895. doi:10.1021/tx400021f
21. Thomas RS, Allen BC, Nong A, Yang L, Bermudez E, Clewell HJ 3rd, Andersen ME (2007) A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. Toxicol Sci 98:240–248. doi:10.1093/toxsci/kfm092
22. Thomas RS et al (2013) Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework. Toxicol Sci 136:4–18. doi:10.1093/toxsci/kft178
23. Vinken M (2013) The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology 312:158–165. doi:10.1016/j.tox.2013.08.011
24. Wetmore BA et al (2012) Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. Toxicol Sci 125:157–174. doi:10.1093/toxsci/kfr254
25. Yang L, Allen BC, Thomas RS (2007) BMDExpress: a software tool for the benchmark dose analyses of genomic data. BMC Genomics 8:387. doi:10.1186/1471-2164-8-387